Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Net Margin (2023 - 2025)

Mangoceuticals (MGRX) has disclosed Net Margin for 3 consecutive years, with 3246.68% as the latest value for Q4 2025.

  • Quarterly Net Margin fell 139546.0% to 3246.68% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 4655.73% through Dec 2025, down 319430.0% year-over-year, with the annual reading at 4784.65% for FY2025, 324078.0% down from the prior year.
  • Net Margin hit 3246.68% in Q4 2025 for Mangoceuticals, up from 9391.8% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 733.99% in Q3 2023 to a low of 9391.8% in Q3 2025.
  • Historically, Net Margin has averaged 2697.86% across 3 years, with a median of 1785.35% in 2024.
  • Biggest five-year swings in Net Margin: surged 143666bps in 2024 and later plummeted -767232bps in 2025.
  • Year by year, Net Margin stood at 1050.87% in 2023, then plummeted by -76bps to 1851.22% in 2024, then plummeted by -75bps to 3246.68% in 2025.
  • Business Quant data shows Net Margin for MGRX at 3246.68% in Q4 2025, 9391.8% in Q3 2025, and 3221.61% in Q2 2025.